BRANMOOR
THURSDAY · 14 MAY 2026

FDA Recall D-0094-2017

B. Braun Medical Inc · Irvine, CA

Class I — life-threatening Terminated 201 days on record

Highest impact — Class I recall — FDA determination of strong likelihood of serious adverse health consequence or death.

Product

5% Dextrose Injection USP, 100mL in a 150 mL PAB container, Rx only, B. Braun Medical Inc. Irvine, CA 92614-5895 USA, NDC 00264-1510-32

Lot / code: Lot #: J5J706, Exp. 10/31/2016

Quantity: 57,408 units

Reason for recall

Non-Sterility: fungal contamination due to leaking containers.

Recall record

Recall number
D-0094-2017
Classification
Class I
Status
Terminated
Voluntary or mandated
Voluntary: Firm initiated
Firm notification
Letter
Distribution
Nationwide
Recall initiated
2016-03-25
Classified by FDA Center
2016-10-12
FDA published
2016-10-19
Terminated
2016-10-12
Recalling firm
B. Braun Medical Inc
Firm location
Irvine, CA

‹ All recalls